Zoom link: https://zoom.us/j/99208865001
11:00 - 11:05 Welcome
11:05 - 11:30 Bernarda Zamora (NIHR London IVD Cooperative, Imperial College London)
Downstaging the most deadly cancer is cost-effective. Can we achieve a cost-effective early diagnosis?
11:30 - 11:55 Diarmuid Coughlan (Newcastle University)
Multiparametric ultrasound in prostate cancer detection: an economic analysis and budget impact analysis
11:55 - 12:20 Alesha Wale (Public Health Wales Evidence Service)
What is the available evidence for the cost-effectiveness of community diagnostic centres?
12:20 - 12:45 Simon Bayliff (Woundcheck Laboratories)
The utility of a point of care bacterial protease test for chronic wounds
12:45 - 13:10 Paola Cocco (University of Leeds)
Early economic modelling to inform a Target Product Profile. A case study of a rapid test for Clostridioides difficile infection
13:10 - 13:30 Lunch Break
13:30 - 14:30 Expert Panel Discussion
This year's panel discussion will focus on the emerging evidence requirements to support health technology assessment of diagnostics and tests. Our panel will include:
• Prof. Chris McCabe (Queen's University Belfast; 2017-2022 CEO & Executive Director the Institute of Health Economics);
• Dr. Bethany Shinkins (University of Leeds; Associate Director of NIHR Leeds In Vitro Diagnostics Co-operative & Member of UK National Screening Committee);
• Dr. Brigitta Monz (Roche Diagnostics International; Access Evidence Chapter Lead, Global Access & Policy)
• Prof. Neil Hawkins (University of Glasgow; Vice Chair of NICE Diagnostics Advisory Committee)
This year will mark the fourth edition of the MEED Research Forum. Our goal is to facilitate the development of methods for economic evaluations (and related studies) of diagnostics and tests by bringing together health economists actively involved in this research area. This year's research forum will take place as a virtual webinar, featuring a series of research presentations and a panel discussion.